Clinical Trials Logo

Clinical Trial Summary

This is a randomized, placebo-controlled, crossover study of Trans Sodium Crocetinate (TSC) in healthy volunteers, age 18-40 (inclusive), exercising at altitude. The primary objective is to determine the effect of (TSC) on partial pressure of oxygen (PaO2) and maximal oxygen consumption (VO2 max); the secondary objective is to assess the effect of TSC on oxygen saturation (SpO2).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05036980
Study type Interventional
Source Diffusion Pharmaceuticals Inc
Contact Kelly Arscott
Phone (443) 375-2906
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date October 2021
Completion date January 2022